Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

TERN (TERN)

Biotechnology

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
P/E (TTM)
EPS
Div Yield
52W Range
Beta

Company overview

Live quote temporarily unavailable — press releases and news are still shown below.

No company overview is available for TERN yet.

Peers in Biotechnology

All in industry →

Recent press releases

April 2026

3 months agoSC 14D9Healthcare

Terns Pharmaceuticals, Inc. — SC 14D9 Filing

TERNTerns Pharmaceuticals, Inc.

# 🧾 What This Document Is This is a **Schedule 14D-9**, a formal "solicitation/recommendation statement." Think of it as Terns' official letter to its shareholders. Its job? To explain the company's board of directors' recommendation on a **major event**—in this case, an acquisition offer from ph

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

TERN has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
8,194,218 sh+47.6%
7,945,608 sh+4.7%
5,550,000 sh+40.9%
5,523,948 sh+21.1%
4,500,000 sh● NEW
5,346,928 sh-22.5%
3,379,569 sh● NEW
3,400,642 sh+104.9%

People at TERN

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
NI -$23.9M
06/25
NI -$24.1M
09/25
NI -$24.6M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.27
Prior: $-0.26
Revenue sparkline